» Articles » PMID: 21148309

MicroRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma Via E-cadherin

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Dec 15
PMID 21148309
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

microRNAs (miRNAs) regulate gene expression at the post-transcriptional level and play important roles in tumor initiation and progression. Recently, we examined the global miRNA expression profile of esophageal squamous cell carcinoma (ESCC) and demonstrated that miR-92a was highly expressed in tumor tissues. In this study, we found that the up-regulation of miR-92a was significantly correlated with the status of lymph node metastasis and TNM stage in 107 ESCC patients. Moreover, the up-regulation of miR-92a was associated with poor survival of ESCC patients and might be used as an independent prognostic factor. Next, we investigated the role and mechanism of miR-92a in ESCC cells, and found that miR-92a modulated the migration and invasion but not apoptosis and proliferation of ESCC cells in vitro. We further demonstrated that miR-92a directly targeted the CDH1 3'-UTR and repressed the expression of CDH1, a tumor metastasis suppressor. In addition, restoring of miR-92a-resistant CDH1 expression in miR-92a-overexpression cells recovered the pro-metastasis activity of miR-92a. Taken together, we demonstrated that miR-92a promotes ESCC cell migration and invasion at least partially via suppression of CDH1 expression, and patients with up-regulated miR-92a are prone to lymph node metastasis and thus have poor prognosis.

Citing Articles

Zinc finger protein ZC3H18 is abnormally expressed in esophageal cancer tissues and facilitates the proliferation of esophageal cancer cells.

Zhang Y, Wan Y, Li J, Ju S, Tong X, Wu J Front Immunol. 2025; 16:1556509.

PMID: 40070828 PMC: 11894379. DOI: 10.3389/fimmu.2025.1556509.


Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer.

Williams M, Howard D, Donnelly C, Izadi F, Parra J, Pugh M Cell Commun Signal. 2024; 22(1):443.

PMID: 39285292 PMC: 11404028. DOI: 10.1186/s12964-024-01806-4.


Exploring the impact of MiR-92a-3p on FOLFOX chemoresistance biomarker genes in colon cancer cell lines.

Escalante P, Quinones L, Contreras H Front Pharmacol. 2024; 15:1376638.

PMID: 38659583 PMC: 11039864. DOI: 10.3389/fphar.2024.1376638.


MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma.

Wei Q, Jin F, Wang Z, Li B, Cao W, Sun Z World J Gastroenterol. 2024; 30(11):1497-1523.

PMID: 38617454 PMC: 11008420. DOI: 10.3748/wjg.v30.i11.1497.


Single Nucleotide Polymorphisms (SNPs) in the Shadows: Uncovering their Function in Non-Coding Region of Esophageal Cancer.

Saikia S, Postwala H, Athilingam V, Anandan A, Padma V, Kalita P Curr Pharm Biotechnol. 2024; 25(15):1915-1938.

PMID: 38310451 DOI: 10.2174/0113892010265004231116092802.


References
1.
Shigoka M, Tsuchida A, Matsudo T, Nagakawa Y, Saito H, Suzuki Y . Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol Int. 2010; 60(5):351-7. DOI: 10.1111/j.1440-1827.2010.02526.x. View

2.
Monzo M, Navarro A, Bandres E, Artells R, Moreno I, Gel B . Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res. 2008; 18(8):823-33. DOI: 10.1038/cr.2008.81. View

3.
Syrigos K, Krausz T, Waxman J, Pandha H, Rowlinson-Busza G, VERNE J . E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer. 1995; 64(6):367-70. DOI: 10.1002/ijc.2910640603. View

4.
Park S, Gaur A, Lengyel E, Peter M . The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008; 22(7):894-907. PMC: 2279201. DOI: 10.1101/gad.1640608. View

5.
Karayiannakis A, Syrigos K, Chatzigianni E, Papanikolaou S, Alexiou D, Kalahanis N . Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. Anticancer Res. 1999; 18(6A):4177-80. View